PetMed Express, Inc. (PETS)

PetMed Express Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	55.3	104.09	111.08	118.72	103.76
Cash & Cash Equivalents	55.3	104.09	111.08	118.72	103.76
Cash Growth	-46.87%	-6.30%	-6.43%	14.41%	3.22%
Receivables	3.28	1.74	1.91	2.59	3.84
Inventory	28.56	19.02	32.46	34.42	17.88
Other Current Assets	6.51	5.58	5.55	5.46	3.53
Total Current Assets	93.65	130.43	151	161.19	129.02
Property, Plant & Equipment	28.09	26.18	24.46	25.45	25.45
Goodwill and Intangibles	43.16	5.86	0.86	0.86	0.86
Other Long-Term Assets	4.99	5.01	3.38	0	0
Total Long-Term Assets	76.24	37.05	28.7	26.31	26.31
Total Assets	169.88	167.48	179.7	187.5	155.32
Accounts Payable	37.02	25.21	27.5	39.55	19.66
Deferred Revenue	2.6	0	0	0	0
Current Debt	0.46	0	0	0	0
Other Current Liabilities	32.07	32.3	28.75	5.39	4.69
Total Current Liabilities	72.16	57.51	56.25	44.94	24.34
Long-Term Debt	1	0	0	0	0
Other Long-Term Liabilities	0	0	0	1.28	0.97
Total Long-Term Liabilities	1	0	0	1.28	0.97
Total Liabilities	73.15	57.51	56.25	46.22	25.31
Total Debt	1.45	0	0	0	0
Retained Earnings	71.56	91.66	111.76	134.14	126.18
Shareholders' Equity	96.73	109.97	123.45	141.28	130.01
Net Cash / Debt	53.84	104.09	111.08	118.72	103.76
Net Cash / Debt Growth	-48.27%	-6.30%	-6.43%	14.41%	3.22%
Net Cash Per Share	2.64	5.12	5.46	5.90	5.17
Working Capital	21.49	72.92	94.75	116.25	104.68
Book Value Per Share	4.74	5.42	6.12	7.04	6.49

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).